Muñoz-Romero I, Moreno-Jiménez S, Vales-Hidalgo O, Hinojosa-González R, Arch-Tirado E, Galván-Hernández EE, Ángel-Celis M, De Leo-Vargas R

Idioma: Español
Referencias bibliográficas: 42
Paginas: 14-24
Archivo PDF: 872.64 Kb.

RESUMEN

Introducción: La incidencia de los schwannomas es de 0.78 a 1.15 casos por cada 100,000 habitantes. Los principales síntomas incluyen deterioro auditivo, tinnitus y vértigo. Su progresión puede causar deterioro neurológico por efecto de masa y compresión del tallo cerebral y nervios craneales. La radiocirugía estereotáctica LINAC-NOVALIS es una alternativa para el tratamiento de este tipo de neoplasias. Objetivo: Demostrar la eficacia del tratamiento con radiocirugía estereotáctica LINAC en pacientes con schwannomas vestibulares. Método: Estudio prospectivo comparativo de 35 pacientes tratados con radiocirugía estereotáctica LINAC. Se efectuó volumetría y audiometría pre y post-radiación. Resultados: Se estudiaron 35 pacientes, predominantemente mujeres (65.7%), con afección más frecuente en el oído izquierdo (57.1%). El volumen promedio de las lesiones disminuyó de 8.11 cm³ a 8.05 cm³, aunque no fue significativo. La capacidad auditiva no fue afectada significativamente (T de Wilcoxon con p = 0.05). Conclusiones: La radiocirugía con LINAC-NOVALIS constituye una alternativa para el tratamiento de los schwannomas vestibulares conforme a estos hallazgos preliminares. Es recomendable dar continuidad a esta línea de investigación en futuras muestras poblacionales.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Machinis TG, Fountas KN et al. History of acoustic neurinoma surgery. Neurosurg Focus 2005; 18 (4): E9.

2. Koerbel A, Gharabaghi A et al. Evolution of vestibular schwannoma surgery: the long journey to current success. Neurosurg Focus 2005; 18 (4): E10.

3. Kondziolka D, Lundsford D, Flickinger C. The radiobiology of the radiosurgery. Neurosurg Clin North Am 1999; 10 (2): 157-166.

4. Porgorsak EB. Physics for radiosurgery with linear accelerator. Neurosurg Clin North Am 1992; 3: 9-34.

5. Altschuler E, Lundsford D, Kondiolka D et al. Radiobiologic models for radiosurgery. Neurosurg Clin North Am 1992; 3(1): 61-78.

6. Yamamoto M, Jimbo M, Kobayashi M et al. Long term results of radiosurgery for AVM: Neurodiagnostic imagining and histological studies for angiographically confirmed nidus obliterans. Surg Neurol 1992; 37: 219-230.

7. Roland PS, Eston D. Stereotactic radiosurgery of acoustic tumors. Otolaryngol Clin North Am 2002; 35 (2): 343-355.

8. Roswell E, Dilys P. Vestibular schwannoma (acoustic neuroma) consensus development conference. Neurosurgery 1992; 30 (6): 962-964.

9. Karpinos M, The BS et al. Treatment of acoustic neuroma: Stereotactic radiosurgery vs microsurgery. Int J Radiation Oncology Biol Phys 2002; 54 (5): 1410-1421.

10. Madjid S, Cordula M. Management of 1,000 vestibular schwannomas (acoustic neuromas): Surgical management and results with an emphasis on complications and how to avoid them. Clinical Study Neurosurgery 1997; 40: 11-23.

11. Bedavanija A, Brieger J et al. Association of proliferative activity and size in acoustic neuroma: implications for timing of surgery. J Neurosurg 2003; 98: 807-811.

12. Kondziolka D, Lundsford D et al. Comparison of management options for patients with acoustic neuromas. Neurosurg Focus 2003; 14 (5): E1.

13. Weber DC, Chan AW et al. Proton beam radiosurgery for vestibular schwannoma: Tumor control and cranial nerve toxicity. Neurosurgery 2003; 53: 577-588.

14. Prasad D, Steiner M et al. Gamma surgery for vestibular schwannoma. J Neurosurg 2000; 92: 745-759.

15. Hasegawa T, Kida Y et al. Long-term outcomes in patients with vestibular schwannomas treated using gamma knife surgery: 10-year follow up. J Neurosurg 2005; 102: 10-16.

16. Rowe JG, Radatz MWR et al. Gamma knife stereotactic radiosurgery for unilateral acoustic neuromas. J Neurol Neurosurg Psychaitry 2003; 74: 1536-1542.

17. Van Eck ATCJ, Horstmann GA et al. Increased preservation of functional hearing after gamma knife surgery for vestibular schwannoma. J Neurosurgery 2005; 102 (Suppl): 204-206.

18. Iwai Y, Yamanaka K et al. Radiosurgery for acoustic neuromas: Results of low-dose treatment. Neurosurgery 2003; 53: 282-288.

19. Inoue HK. Low-dose radiosurgery for vestibular sachwannomas: long-term results of functional preservation. J Neurosurg 2005; 102 (Suppl): 111-113.

20. Flickinger JC, Kondziolka D et al. Results of acoustic neuroma radiosurgery: an analysis of 5 years experience using current methods. J Neurosurg 2001; 94: 1-6.

21. Hasegawa T, Fujitani S et al. Stereotactic radiosurgery for vestibular schwannomas: Analysis of 317 patients followed for more than 5 years. Neurosurgery 2005; 57; 257-265.

22. Litvack ZN, Norén G et al. Preservation of functional hearing after gamma knife surgery for vestibular schwannoma. Neurosurg Focus 2003; 14 (5): E3.

23. Kondziolka D, Lundsford D et al. Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 1998; 339: 1426-1433.

24. Roland PS, Eston D et al. Stereotactic radiosurgery of acoustic tumors. Otolaryngol Clin N Am 2002; 35: 343-355.

25. Nakamura H, Jokura H et al. Serial follow-up MR Imaging after gamma knife radiosurgery for vestibular schwannoma. AJNR Am J Neuroradiol 2000; 21: 1540-1546.

26. Ping Ch, Chung JY et al. Sequential volume mapping for confirmation of negative growth in vestibular schwannomas treated by gamma knife radiosurgery. J Neurosurg 2000; 93 (Suppl 3): 82-89.

27. Del Valle R, Pérez M et al. Stereotactic noninvasive volume measurement for indications and evaluation of gamma knife treatment. J Neurosurg 2005; 102 (Suppl): 140-142.

28. Spiegelman R, Vilidar Z et al. Linear accelerator radiosurgery for vestibular schwannoma. J Neurosurg 2001; 94: 7-13.

29. Friedman W, Foote KD. Linear-accelerator based radiosurgery for vestibular schwannoma. Neurosurg Focus 2003; 14 (5): E2.

30. Foote KD, Friedman WA et al. Analysis of risk factors associated with radiosurgery for vestibular schwannoma. J Neurosurg 2001; 95: 440-449.

31. Chan AW, Black P McL et al. Stereotactic radiotherapy for vestibular schwannomas: Favorable outcome with minimal toxicity. Neurosurgery 2005; 57: 60-70.

32. Selch MT, Pedroso A et al. Stereotactic radiotherapy for the treatment of acoustic neuromas. J Neurosurg 2005; 101 (Suppl 3): 362-372.

33. Petit JH, Hudes RS et al. Reduced-dose radiosurgery for vestibular schwannomas. Neurosurgery 2001; 49 (6): 1306-1307.

34. Chang SD, Poen J et al. Acute hearing loss following fractionated stereotactic radiosurgery for acoustic neuroma. J Neurosurg 1998; 89: 321-325.

35. Hasegawa T, Kida Y et al. Evaluation of tumor expansion after stereotactic radiosurgery in patients harboring vestibular schwannomas. Neurosurgery 2006; 58: 1119-1128.

36. Pollock BE. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: Treatment recommendations based on a 15 year experience. Neurosurgery 2006; 58: 241-248.

37. Sakamoto T, Shirato H et al. Medication for hearing loss after fractionated stereotactic radiotherapy (SRT) for vestibular schwannoma. Int J Radiat Oncol Biol Phys 2001; 50: 1295-1298.

38. Pollock BE, Lundsford LD et al. Vestibular schwannoma management in the next century: A radiosurgical perspective concept. Neurosurgery 1998; 43: 475-483.

39. Gardner G, Robertson JH. Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laringol 1988; 97; 55-66.

40. Otolaryngology-Head and Neck Surgery. Committee on hearing and equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol Head Neck Surg 1995; 113 (3): 1-4.

41. Douglas D. Backous, Huong T. Pham, guiding patients through the choices for treating vestibular schwannomas: balancing options and ensuring informed consent. Neurosurg Clin N Am 2008; 19: 379-392.

42. Greenberg MS. Handbook of neurosurgery. Estados Unidos de América, 5ta ed., Estados Unidos de América: Editorial Thieme; 2001: 974.